News

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...
The conversation centred on the company’s latest developments and strategic direction in cancer therapies, with a particular ...
Geoffrey S. Ginsburg ( [email protected]) is director of the Duke Center for Applied Genomics and Precision Medicine, Duke University, in Durham, North Carolina. Kathryn A. Phillips is a ...
The Ibero-American Consortium gathers over 3000 DNA samples to drive precision strategies for rheumatoid arthritis and ...
Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...
We are in an age where medicine is no longer one-size-fits-all; personalised healthcare is changing the diagnosis and ...
Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development, ...
Advances have made cancer therapies more effective through targeting specific molecules. Companion diagnostics (CDx) are ...
Danaher Corporation DHR recently partnered with AstraZeneca PLC AZN to develop and market novel diagnostic tools aimed at ...
Early detection and targeted treatment of cardiovascular diseases to extend healthy lifespans are becoming increasingly achievable due to advances in precision medicine. Ulf Landmesser ...
Panelists discuss how the future of polycythemia vera (PV) management will be shaped by advancements in targeted therapies, ...
BETHESDA, Md., May 20, 2025 /PRNewswire/ -- Precision for Medicine, an operating unit of Precision Medicine Group and a leading next-generation provider of drug development and commercialization ...